Northeast Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Northeast Pharmaceutical Group has a total shareholder equity of CN¥5.2B and total debt of CN¥2.3B, which brings its debt-to-equity ratio to 44.1%. Its total assets and total liabilities are CN¥14.7B and CN¥9.5B respectively. Northeast Pharmaceutical Group's EBIT is CN¥591.1M making its interest coverage ratio -29.5. It has cash and short-term investments of CN¥4.9B.
Key information
44.1%
Debt to equity ratio
CN¥2.30b
Debt
| Interest coverage ratio | -29.5x |
| Cash | CN¥4.89b |
| Equity | CN¥5.21b |
| Total liabilities | CN¥9.46b |
| Total assets | CN¥14.67b |
Recent financial health updates
Recent updates
It's A Story Of Risk Vs Reward With Northeast Pharmaceutical Group Co., Ltd. (SZSE:000597)
Aug 07
These 4 Measures Indicate That Northeast Pharmaceutical Group (SZSE:000597) Is Using Debt Safely
May 25Northeast Pharmaceutical Group (SZSE:000597) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Apr 05Financial Position Analysis
Short Term Liabilities: 000597's short term assets (CN¥9.4B) exceed its short term liabilities (CN¥9.0B).
Long Term Liabilities: 000597's short term assets (CN¥9.4B) exceed its long term liabilities (CN¥435.1M).
Debt to Equity History and Analysis
Debt Level: 000597 has more cash than its total debt.
Reducing Debt: 000597's debt to equity ratio has reduced from 83.1% to 44.1% over the past 5 years.
Debt Coverage: 000597's debt is well covered by operating cash flow (29.4%).
Interest Coverage: 000597 earns more interest than it pays, so coverage of interest payments is not a concern.